Skip to main content

Discovering next-generation treatments for the mind and body

Kibow’s management team, board of directors and scientific advisory boards are industry leaders with extensive experience in bringing new pharmaceuticals from discovery to market. This experience with drug development and clinical practice and research allows Kibow to rapidly advance a pipeline of proprietary, optimized and scalable mental health and pain management medicines.

We Strive to Improve Outcomes with Our Novel Adjunctive CKD Therapies

Chronic kidney disease (CKD) is characterized by a gradual loss of kidney function. As many as one in nine U.S. adults has CKD. Kibow Therapeutics is advancing novel, non-invasive therapies to improve quality of life and slow the progression of CKD.